Patents for C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334) |
---|
05/27/2014 | US8735420 Polymorphic forms of naltrexone |
05/22/2014 | US20140142132 Peripheral opioid receptor antagonists and uses thereof |
05/20/2014 | US8729266 Preparation of N-alkylated opiates by reductive amination |
05/20/2014 | CA2646313C Stereoselective reduction of a morphinone |
05/20/2014 | CA2630703C Processes for reducing contaminating michael acceptor levels in oxycodone and other compositions |
05/15/2014 | WO2012058695A3 Compositions of (-)-17-(cyclobutylmethyl) morphinan-3, 14-diol |
05/14/2014 | EP2730578A1 Preparation and use of (r),(r)-2,2'-bis-methylnal trexone |
05/14/2014 | EP2729469A1 Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse |
05/08/2014 | WO2014070745A1 Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof |
05/06/2014 | US8716278 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder |
05/06/2014 | US8715721 Controlled release hydrocodone |
04/29/2014 | US8710226 Process for the preparation of morphinane analogues |
04/29/2014 | US8709431 Enediyne compounds, conjugates thereof, and uses and methods therefor |
04/29/2014 | CA2597350C Process for purifying noroxymorphone compounds |
04/24/2014 | US20140112981 Controlled release hydrocodone formulations |
04/22/2014 | US8703950 Low ABUK oxycodone, its salts and methods of making same |
04/22/2014 | US8703949 Tandem process for preparing N-alkyl morphinans |
04/16/2014 | CN101805343B Chemically modified small molecules |
04/09/2014 | EP2714695A1 Crystalline, anhydrous forms of oxymorphone hydrochloride |
04/08/2014 | US8691989 Methods of synthesis of morphinans |
04/02/2014 | CN103690540A Controlled release hydrocodone formulations |
04/01/2014 | US8685996 Methods for making 3-O-protected morphinones and 3-O-protected morphinone dienol carboxylates |
03/27/2014 | US20140088132 Crystalline, anhydrous forms of oxymorphone hydrochloride |
03/26/2014 | CN103664967A Method for synthesizing [2H3]-morphine |
03/12/2014 | EP2705043A1 Processes and intermediates in the preparation of morphine analogs via n-demethylation of n-oxides using cyclodehydration reagents |
03/12/2014 | EP2705040A1 Process for the preparation of morphine analogs via metal catalyzed n-demethylation/functionalization and intramolecular group transfer |
03/12/2014 | CN103626782A Preparation method of methylnaltrexone bromide |
03/06/2014 | WO2014033530A1 1,3-dioxanomorphides and 1,3-dioxanocodides |
03/05/2014 | EP2703404A1 Buprenorphine analogs |
03/05/2014 | CN103619847A Process for the preparation of morphine analogs via metal catalyzed N-demethylation/functionalization and intramolecular group transfer |
02/27/2014 | US20140057931 Buprenorphine analogs |
02/20/2014 | US20140051861 Process for preparing oxymorphone, naltrexone, and buprenorphine |
02/19/2014 | CN103596962A Processes and intermediates in the preparation of morphine analogs via N-demethylation of N-oxides using cyclodehydration reagents |
02/18/2014 | US8653271 Enhancing transdermal delivery of opioid antagonists and agonists using codrugs linked to bupropion or hydroxybupropion |
02/18/2014 | US8653065 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder |
02/13/2014 | US20140045876 Process |
02/11/2014 | US8647667 Controlled release hydrocodone formulations |
02/11/2014 | CA2628971C Therapeutic or prophylactic agent for functional bowel disorder |
02/06/2014 | WO2014022733A1 A method for preparing oxycodone |
02/04/2014 | US8642615 Methods of using 8-carboxamido-2,6-methano-3-benzazocines |
01/30/2014 | US20140031550 Process for the preparation of morphinane analogues |
01/30/2014 | US20140031543 (+)-6-Hydroxy-Morphinan or (+)-6-Amino-Morphinan Derivatives |
01/28/2014 | US8637539 Remedies for neuropathic pain and model animals of neuropathic pain |
01/23/2014 | WO2014013313A1 Process for improved opioid synthesis |
01/23/2014 | WO2014013311A1 Process for improved opioid synthesis |
01/09/2014 | US20140013465 Papaver bracteatum with modified alkaloid content |
01/08/2014 | CN101959892B Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone |
01/07/2014 | US8624031 Production of alkaloids without the isolation of intermediates |
01/07/2014 | US8624030 N-demethylation of 6-keto morphinans |
01/07/2014 | US8623888 3-oxy-hydromorphone derivatives |
01/02/2014 | US20140005215 Selective Opioid Compounds |
01/02/2014 | US20140004188 Crystal forms of (r)-n-methylnaltrexone bromide and uses thereof |
12/26/2013 | US20130345251 Large substituent, non-phenolic opioids and methods of use thereof |
12/24/2013 | US8614224 Sinomenine derivatives and processes for their synthesis |
12/19/2013 | WO2013188418A1 Improved method of preparing oxymorphone |
12/19/2013 | US20130338365 Nalmefene hydrochloride dihydrate |
12/18/2013 | CN103450206A Buprenorphine analogs |
12/17/2013 | US8609682 Analgesic agents |
12/12/2013 | WO2013184902A1 Chemical transformations of (-)-codeine to afford derivatives of codeine and morphine thereof |
12/05/2013 | US20130323286 Synthesis of r-n-methylnaltrexone |
12/03/2013 | US8598352 Preparation of nalmefene hydrochloride from naltrexone |
11/27/2013 | CN103408553A Refinement technique of hydromorphone acid salt |
11/27/2013 | CN103405431A Opioid and opioid-like compounds and uses thereof |
11/27/2013 | CN102127086B Method for preparing oxycodone hydrochloride having less than 25 ppm 14- hydroxycodeinone |
11/20/2013 | EP2398808B1 Process for the reductive alkylation of normorphinans |
11/20/2013 | EP2125824B1 Improved preparation of oxymorphone from oripavine |
11/14/2013 | WO2013168011A1 Compositions and methods for the treatment of chronic pain |
11/14/2013 | US20130302418 Controlled release hydrocodone formulations |
11/13/2013 | CN103387579A Synthesis of 4-benzyloxy-17-benzenesulfonylmorphinan-6-one |
11/13/2013 | CN103387578A Synthesis of 4-fluorobenzyloxy-6-hydroxy morphinan alkyl |
11/13/2013 | CN102351869B Preparation method of high-purity methylnaltrexone bromide |
11/12/2013 | US8580963 Method for the manufacturing of naltrexone |
11/12/2013 | CA2610859C A synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs |
11/07/2013 | WO2013166271A1 Heterocycle-fused morphinans, use thereof and preparation thereof |
11/07/2013 | WO2013164383A1 Method for the manufacturing of naltrexone |
11/07/2013 | WO2013163668A1 Papaver bracteatum with modified alkaloid content |
11/07/2013 | WO2013050748A3 Process for preparing buprenorphine |
11/07/2013 | US20130296570 Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone |
11/07/2013 | US20130295177 Controlled release hydrocodone |
11/06/2013 | CN101801978B Methods for one-pot N-demethylation/N-acylation of morphine and tropane alkaloids |
10/31/2013 | US20130289060 6-AMIDO DERIVATIVES OF 4, 5-a EPOXYMORPHINANS FOR THE TREATMENT OF PAIN |
10/29/2013 | US8569228 Compositions comprising enzyme-cleavable oxycodone prodrug |
10/24/2013 | US20130281698 Novel 6-Amino-Morphinan Derivatives, Method of Manufacturing Them and Their Application as Analgesics |
10/22/2013 | US8563726 Stereoselective reduction of a morphinone |
10/22/2013 | US8563725 Preparation of saturated ketone morphinan compounds having low metal content |
10/22/2013 | US8563724 (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives |
10/22/2013 | US8563721 Morphinan derivatives and preparation methods thereof |
10/22/2013 | US8563571 Crystalline forms of oxymorphone hydrochloride |
10/22/2013 | CA2538146C Pyridomorphinans, pyridazinomorphinans and use thereof |
10/16/2013 | CN101208345B (S)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use |
10/08/2013 | US8551520 Controlled release hydrocodone |
10/01/2013 | US8546572 Process for the preparation of morphinane analogues |
10/01/2013 | US8546418 Peripheral opioid receptor antagonists and uses thereof |
10/01/2013 | CA2557845C Process for preparing, and composition and pharmaceutical dosage forms containing, an oxycodone salt having less than 25 ppm 14-hydroxycodeinone |
09/26/2013 | US20130253199 Polymorphic Forms of Naltrexone |
09/26/2013 | US20130252994 Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof |
09/18/2013 | EP2639234A1 Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same |
09/18/2013 | CN103304570A Naloxone hydrochloride compound as well as preparation method and pharmaceutical composition of naloxone hydrochloride compound |
09/17/2013 | US8536192 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
09/17/2013 | US8536191 Crystalline and amorphous forms of nalbuphine hydrochloride |